Establishing guidance for the handling and containment of new chemical entities and chemical intermediates in the pharmaceutical industry.
This information is intended to guide scientists and technicians working with pharmaceutical substances early in development, before occupational exposure levels (OELs) can be set. The focus is on determining hazard categories, or occupational exposure bands, which may be applied temporarily until full health-based OEL's are in place.
Olson
M J
MJ
Glaxo Wellcome, Inc. Research Triangle Park, North Carolina 27709, USA.
Binks
S P
SP
Newton
D L
DL
Clark
G C
GC
D003264:Containment of Biohazards / Q000379:methods / Q000592:standards*; D004345:Drug Industry / Q000379:methods / Q000592:standards*; D017408:Guidelines as Topic; D015386:Hazardous Substances / Q000009:adverse effects* / Q000145:classification; D006801:Humans; D016273:Occupational Exposure / Q000145:classification / Q000517:prevention & control*; D016272:Occupational Health; D018570:Risk Assessment; D014481:United States
D015386:Hazardous Substances